Voyager Therapeutics

Biotech & Life Sciences · Cambridge, United States · Founded 2014 · IPO 2015

Gene therapies for neurological diseases crossing blood-brain barrier.

Valuation $76M

Revenue $39M

Power Law Thoroughbred$100M+ revenue

Talent graph

Voyager Therapeutics's talent

Book a demo to see the people

Employees mapped 161 incl. 5 AI specialists

Founders /100 quality score

Key operators 8 quality /100

Potential founders likely future founders

Startup mafia 4 alumni-founded startups

Talent movements in · out past 12 months

Source: Dealroom Talent Intelligence.

Investors

11 investors on Voyager Therapeutics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 1 investor entered at this stage

Third Rock Ventures

Series B+ 10 investors entered at this stage

Wellington Management

Casdin Capital

Brookside Capital

PFM Health Sciences

University of Massachusetts Medical School

Fidelity Investments

University of California

San Francisco

Foresite Capital

Stanford University

Voyager Therapeutics mafia

Startups founded by Voyager Therapeutics alumni

Former Voyager Therapeutics employees who went on to start their own companies. Sorted by Dealroom signal score.

Seaport TherapeuticsEst. 2024

Steven PaulUnited States

Signal score93

Vima TherapeuticsEst. 2023

Bernard RavinaUnited States

Signal score91

LogicBio TherapeuticsEst. 2015

Mark MdUnited States

Signal score63

Generation BioEst. 2016

Robert KotinUnited States

Signal score62

Book a demo to explore the full alumni network →

Global footprint

Where Voyager Therapeutics has talent and traffic

Workforce by country

2 countries with
team presence

🇺🇸 United States99.3%

🇲🇽 Mexico0.7%

2 countries shown

Web traffic by country

11K monthly visits
across markets

🇺🇸 United States78.2%

🇬🇧 United Kingdom7.3%

🇮🇳 India6.4%

🇦🇺 Australia5.5%

Top 4 markets shown

Patent intelligence

$42M patent portfolio · 80 active families

Estimated portfolio value

$42M

55.3% of market cap · comparable to top peer Spark Therapeutics ($46M)

80 active patent families

Where Voyager Therapeutics innovates Adeno-associated virusBiochemistryBioinformaticsCapsidCell biology

Where Voyager Therapeutics concentrates vs peers

Each axis is a top-10 topic across Voyager Therapeutics and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Voyager Therapeutics

An AI-synthesized read of the highest-engagement posts about Voyager Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Voyager Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles